INTRODUCTION
Fibrotic diseases have been shown to be associated with excessive deposition of extracellular matrix (ECM) (Wells, 2008; Cox & Erler, 2011; Klingberg et al., 2013) . The accumulation of ECM is thought to be primarily due to an impaired ECM turnover (Duymelinck et al., 1998) . ECM degradation is mainly regulated by the action of two matrixdegrading enzyme systems, the matrix metalloproteinases and the plasminogen activators and their intrinsic inhibitors, the tissue inhibitors of metalloproteinases (TIMPs) and the plasminogen activator inhibitors, respectively (Woessner, 1991; Eddy, 2000) . Transforming growth factor- (TGF- and downstream Smad signaling pathways have been found to be the most important pathways involved in tissue fibrosis via induction of profibrotic genes (Roberts & Sporn, 1990; Gore-Hyer et al., 2002; Ruiz et al., 2003) . Generally, TGF-induces ECM deposition by stimulating the expression of ECM proteins such as connective tissue growth factor (CTGF), reducing synthesis of ECM degrading enzymes such as matrix metalloproteinases-9 (MMP-9) and up-regulating synthesis of proteinase inhibitors such as tissue inhibitors of metalloproteinase-1 (TIMP-1) (Roberts & Sporn, 1990; Gore-Hyer et al., 2002; Ruiz et al., 2003; Weng et al., 2007; Wang et al., 2011) . TGF-is usually secreted as latent complex (latent TGF-β) consisting of TGF-β covalently bound to latent TGF-β binding proteins (LTBP) (Roberts, 1998; Okada et al., 2005) . Activation of TGF-is achieved by either proteolytic or nonproteolytic events (Annes et al., 2003) and in some cases may include a redox-sensitive mechanism (Barcellos-Hoff & Dix, 1996; Jobling et al., 2006) . In this respect, oxidation of the latency-associated peptide can cause a conformational change that releases TGF-β (Barcellos-Hoff & Dix, 1996) . Mechanistically, activated TGF- acts through a heteromeric receptor complex. The predominant type 1 receptor for TGF- signaling is thought to be activin receptor-like kinase (ALK)-5 which phosphorylates Smad-2 and Smad-3 and subsequently forms a complex with the co-Smad, Smad-4, and translocates into the nucleus. Subsequently, these complexes bind with a high affinity to specific promoter elements, the Smad binding elements (SBE), and thereby can activate the transcription of many TGF--induced target genes, including CTGF (Fukasawa et al., 2004) and TIMP-1 (Marti et al., 1994; Chen et al., 2002) . Cyclosporin A (CsA) is one of the most efficient immunosuppressive agents that suppress T-cell activation by inhibiting the cellular phosphatase calcineurin (Schreiber & Crabtree, 1992) and therefore is widely used in organ transplantation and many inflammatory diseases including psoriasis, and rheumatoid arthritis. Recently, CsA has been shown to cause a rapid activation of TGF-/Smad signaling pathway in glomerular mesangial cells and thereby increase the expression of the profibrotic genes CTGF and TIMP-1 (Akool et al., 2005 and 2008) . The present work was designed to test the possible modulation of TGF-/Smad signaling pathway by CsA in pulmonary epithelial cells (A549 cells) that are considered as a source of TGF- in the lung (Kwong et al., 2004) .
MATERIALS AND METHODS

Materials
The TGF-RI kinase inhibitor [3-(pyridin-2-yl)-4-(4-quinonyl)]-1H-pyrazole (Alk-5 inhibitor), U0126, SP600125 and SB203580 were obtained from Calbiochem (Germany). Diphenylene iodonium (DPI), N-acetyl cysteine (NAC) were purchased from Sigma-Aldrich (Taufkirchen, Germany). Human recombinant TGF 1 was purchased from Cell Concepts GmbH (Umkirch, Germany). CsA was purchased from Alexis Biochemicals (Germany). A neutralizing monoclonal TGF 1-3 antibody and Human TGF- 1 Quantikin-e ELISA Kit were purchased from R&D Systems (Wiesbaden-Nordenstadt, Germany). Antibodies specifically raised against phospho-Smad-2, total Smad-2 were derived from Cell Signaling (Frankfurt am Main, Germany). Antibodies against CTGF, TIMP-1, -actin and anti-rabbit HRPlinked IgGs, as well as control IgG were obtained from Santa Cruz Biotechnology (Heidelberg, Germany). The ECL system, and Hyperfilm were purchased from Amersham Pharmacia Biotech (Germany).
Cell Culture
Human A549 lung epithelial/carcinoma cells were obtained from the German Collection of Microorganisms and Cell Cultures (Braunschweig, Germany). Cells were cultivated in RPMI 1640, supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin, 10% heatinactivated FCS and 10mM HEPES buffer (GIBCOBRL, Eggenstein, Germany).
Western Blot Analysis
For detection of CTGF, TIMP-1, phosphorylated Smad-2 and total Smad-2, wholecell lysates were prepared. Total cell extracts containing 50-100 µg of protein were prepared in sodium dodecyl sulfate (SDS) sample buffer and subjected to SDS-polyacrylamide gel electrophoresis (PAGE) and Western blot analysis was performed as originally described by Laemmli (1970) . In general, a total protein (50-100µg) from each sample was mixed with an equal volume of 2x electrophoresis sample buffer and incubated at 95C for 10 minutes for denaturation. Following gel electrophoresis, the proteins were transferred onto a nitrocellulose (PVDF) membrane by semi-dry electroblotting. After blocking (by shaking the membrane in 5% bovine serum albumin (BSA) in Tris-buffered saline containing 0.05% Tween for 1 hour, the membrane was incubated with the primary antibody overnight at 4C followed by incubation with secondary antibodies (coupled to horseradish peroxidase). Signals were detected using enhanced chemi luminescence (ECL) reagent according to the manufacturer's instructions.
ELISA
Levels of TGF- in cell-free culture supernatants were determined by enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions (R&D Systems, Wiesbaden-Nordenstadt, Germany).
Statistical Analysis
Results are expressed as means ± SD. Statistical analysis was performed using Student's t test and for multiple comparisons the ANOVA test for significance. P-values below 0.05 were considered as indication for statistically significant differences between conditions compared.
RESULTS
Cyclosporin A rapidly activates Smad-2 in A549 cells
First to test whether CsA similar to TGF- could induce phosphorylation of Smad-2 a direct target of the activated type I TGF- receptor. A549 cells were stimulated with either vehicle (control) or CsA or TGf- for different time points. Stimulation of A549 cells with CsA induced a rapid phosphorylation of Smad-2 with maximal effect seen after 60 min (Fig.1A) . This was not associated with change in the total Smad-2 content. TGF-, a potent activator of Smads was used as a positive control. As expected, TGF- 1 caused a strong increase in Smad-2 phosphorylation (Fig. 1A) . (1µM) for the indicated time points. Thereafter, total extracts were isolated and Western blot analysis was performed using specific anti-phospho-Smad-2 at a dilution of 1:1000 each. For ascertainment that the total level of Smad-2 remained unchanged, blots were stripped and reprobed with the antibody raised against total Smad-2. B, A549 cells were stimulated with either vehicle for 60 min. or different doses of CsA (µM) for 60 min. Thereafter, total extracts were isolated and Western blot analysis was performed as previously described. The lower panels show a densitometric analysis of p-Smad-2 relative to total Smad-2 level. Data represent means  S.D. (n=3), * p < 0.05, ** p < 0.01 versus control. One representative of three independently performed experiments is shown.
CsA Activates Smad-2 in dose-dependent manner
To check the effect of different doses of CsA on Smad-2 activation, A549 cells were stimulated with different doses of CsA. As shown in Fig.1B CsA activates Smad-2 in a dosedependent manner with maximal effect seen at a dose of 1µM.
Activation of Smad-2 by CsA in A549 cells depends on extracellular TGF- and involves TGF--RI kinase
To delineate the mechanism by which CsA activates Smad-2, the involvement of extracellular TGF-as well as TGF--RI kinase in Smad-2 phosphorylation induced by CsA was tested using pan-specific TGF- antibody and the specific-TGF--RI kinase inhibitor which has demonstrated a high TGF--inhibitory potential in vitro and in vivo. A549 cells were preincubated without (+ vehicle) or with either 20µg/ml of pan-specific TGF- antibody (+ anti-TGF a.b.) or, alternatively, with the same amount of control IgG (+ IgG) or 100nM of TGF--RI kinase inhibitor before cells were additionally treated with Figure 2 . CsA-triggered Smad-2 phosphorylation depends on extracellular TGF-and TGF-RI kinase activity in A549 cells. A549 cells were pretreated for 60 min with either vehicle or pan-specific TGF- antibody (20µg/ml) or the same amount of control IgG or TGF- RI kinase inhibitor (100nM) before cells were stimulated for a further 60 min with either vehicle (-) or CsA. Thereafter, total extracts were isolated and Western blots successively probed with anti-phospho-Smad-2. For ascertainment that the total level of Smad-2 remained unchanged, blots were stripped and reprobed with the antibody raised against total Smad-2. The lower panel shows a densitometric analysis of p-Smad-2 relative to total Smad-2 level. Data represent means ± S.D. (n=3), * p < 0.05, ** p < 0.01 versus control, ## p < 0.01 versus CsA alone-treated animals. One representative of three independently performed experiments is shown.
CsA for 60min (Fig. 2) . The neutralization of TGF- caused a significant reduction in CsAinduced Smad-2 phosphorylation, whereas addition of isotype-specific control IgG (+IgG) had no effect on p-Smad-2 levels (Fig. 2) . Furthermore, it was found that preincubation of A549 cells with 100 nM of the TGF--RI kinase inhibitor totally prevented basal as well as CsA-dependent Smad-2 phosphorylation (Fig. 2) . A549 cells were preincubated with NAC (5mM) or DPI (10µM) for I hour before stimulation with CsA for further hour. After stimulation with CsA, Cell supernatants were collected and assessed for active TGF- 1 by Quantikine ELISA (B). Thereafter, total extracts were isolated and Western blots successively probed with anti-phospho-Smad-2. For ascertainment that the total level of Smad-2 remained unchanged, blots were stripped and reprobed with the antibody raised against total Smad-2 (A). C, D. A549 cells were stimulated for 60 min with CsA in the absence or presence of different MAPK inhibitors, SB203580 (10µM), U0126 (20 µM), SP600125 (10µM), which were preincubated for 60 min. After stimulation with CsA, Cell supernatants were collected and assessed for active TGF- 1 by Quantikine ELISA (D). Thereafter, total extracts were isolated and Western blot analysis was performed as previously described (C). Data represent means ± S.D. (n=3), * p < 0.05, ** p < 0.01 versus control, ## p < 0.01 versus CsA alone-treated animals. One representative of three independently performed experiments is shown.
ROS but not MAPKs are required for TGF- activation and subsequent smad-2 phosphorylation by CsA in A549 cells
To check the involvement of ROS in Smad-2 activation by CsA, A549 cells were preincubated with either NAC a ROS scavenger or DPI, an inhibitor of NADPH oxidases for 1 hour before stimulation with CsA for further hour. In contrast to DPI, NAC caused a significant inhibition of CsA-induced Smad-2 activation (Fig. 3A) . Interestingly, this inhibitory effect of NAC on CsA-induced Smad-2 phosphorylation was associated with reduction in TGF- released by CsA (Fig. 3B) . The involvement of MAPK activity in Smad-2 phosphorylation by CsA was also investigated. As shown in Fig. 3C , neither p38 MAPK inhibitor (SB203580) nor p44/42 MAPK inhibitor (U0126) nor JNK inhibitor (SP600125) were able to inhibit Smad-2 phosphorylation induced by CsA. Furthermore, the release of TGF-by CsA was not affected in the presence of MAPK inhibitors (Fig. 3D) . 
ROS and TGF-are required for CTGF and TIMP-1 expression induced by CsA in A549 cells
As shown in Fig.4 , stimulation of A549 cells with CsA increased the expression of CTGF (Fig. 4A ) and TIMP-1 (Fig. 4B) . However, preincubation with a neutralizing pan-specific TGF- antibody (+ anti-TGF a.b) caused a strong reduction in CsA-induced expression of CTGF (Fig. 4A ) and TIMP-1 (Fig. 4B) . Furthermore, preincubation with NAC caused a clear reduction in CsA-induced expression of CTGF (Fig. 4A ) and TIMP-1 (Fig. 4B) .
DISCUSSION
TGF- and downstream Smad signaling pathways have been found to be the most important pathways involved in tissue fibrosis by increasing the expression of the profibrotic genes CTGF and TIMP-1 (Roberts & Sporn, 1990; Gore-Hyer et al., 2002; Ruiz et al., 2003; Weng et al., 2007; Wang et al., 2011) . It has been reported that the profibrotic actions of the immunosuppressive drug CsA is attributable to an autocrine synthesis of TGF- (Wolf et al., 1993; Pankewycz et al., 1996; Khanna et al., 1999 ) , and some studies have demonstrated a transcriptional effect on TGF- expression by CsA both in vitro (Prashar et al., 1995) and in vivo (Citterio et al., 2004; Gao et al., 2006) . Recently, it has been demonstrated that CsA causes a rapid activation of TGF-β/Smad signaling cascades in renal mesangial cells (Akool et al., 2008) and thereby increase the expression of the profibrotic genes CTGF and TIMP-1 (Akool et al., 2005 and 2008) . The present work was designed to test the possible modulation of TGF-/Smad signaling pathway by CsA in pulmonary epithelial cells (A549 cells) that are considered as a source of TGF- in the lung (Kwong et al., 2004) . It was found that treatment of A549 cells with CsA caused a rapid phosphorylation of Smad-2 in dose-and timedependent manner (Fig. 1) . To delinate the underlying mechanisms involved in Smad signaling activation by CsA, A549 cells were treated with a specific kinase inhibitor of the type I TGF- receptor denominated as ALK-5 inhibitor, and a neutralizing TGF- antibody before stimulation with CsA. It was observed that TGF- receptors and TGF- release are indispensable for Smad-2 activation by CsA (Fig. 2) . Mechanistically, the release of TGF-β from the latent TGF- binding protein (LTBP) complex can be achieved by either proteolytic or nonproteolytic events (Annes et al., 2003.) and in some cases may include a redoxsensitive mechanism (Barcellos-Hoff & Dix, 1996; Jobling et al., 2006) . In this context, oxidation of the latency conferring peptide can cause a conformational change that releases TGFβ (Barcellos-Hoff & Dix, 1996) . Previous studies have demonstrated that CsA at different concentrations promotes the generation of ROS by a mechanism that is independent of cytochrome P-450 oxidases (Krauskopf et al., 2002) and NADPH oxidases (Krauskopf et al., 2005) , the major cellular superoxide-generating enzymes. In full agreement with these studies, It was found that preincubation of A549 cells with the ROS scavenger Nacetylcysteine (NAC) before stimulation with CsA highly reduced the Smad-2 activation (Fig. 3A) . In contrast, nothing changed with Smad-2 activation when the cells were preincubated with DPI (NADPH oxidase inhibitor) before stimulation with CsA indicating that NADPH oxidase is not the source of ROS in A549 cells (Fig. 3A) . Most interestingly, this inhibitory effect of NAC on CsA-induced Smad-2 phosphorylation was associated with reduction in TGF- released by CsA (Fig. 3B) indicating that ROS generation is required for TGF- release and subsequent Smad-2 phosphorylation induced by CsA in A549 cells. MAPKs have been implicated in Smads signaling (Javelaud & Mauviel, 2005; Akool et al., 2008) . Therefore, the involvement of MAPK activity in Smad-2 phosphorylation was tested. In contrast to previous finding but in other system (Akool et al., 2008) , it was found that MAPKs are not involved in Smad-2 phosphorylation induced by CsA in A549 cells (Fig.  3C) . Furthermore, the release of TGF-induced by CsA was not affected in the presence of MAPK inhibitors (Fig. 3D) indicating that MAPK activity is not involved in TGF- release as well as Smad-2 phosphorylation induced by CsA. To test whether the Smad-2 activation induced by CsA would functionally correlate with an up-regulation of Smad controlled gene expression, CTGF and TIMP-1 expression were investigated. In agreement with previous findings but in other system (Akool et al., 2008) , treatment of A549 cells with CsA induces CTGF (Fig. 4A) and TIMP-1 (Fig. 4B) expression. Most interestingly, preincubation of the cells with a neutralizing TGF- antibody or NAC before stimulation with CsA caused a strong reduction in CsA-induced expression of CTGF (Fig. 4A) and TIMP-1 (Fig. 4B) indicating that ROS and TGF- are required for the induction of CTGF and TIMP-1 expression by CsA in A549 cells. In summary, CsA causes a rapid activation of the fibrogenic Smad signaling cascade in A549 cells via generation of ROS and subsequent activation of latent TGFβ that is sufficient to elicit fibrogenic cell responses as indicated by increasing the expression of the fibrogenic genes CTGF and TIMP-1 that play an important role in tissue fibrosis. The potential blockade of TGF-/Smad signaling pathway, either by anti-TGF Abs or antioxidant treatment, may emphasize the concept of therapeutic TGF neutralization in combination with antioxidant therapy as a valuable approach for the prevention of CsA-induced profibrotic genes. 
